- AdventHealth Research Institute
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity. Most of what we know about this comes from animal studies or human observations, so there is still a lot to learn.
Our recent study, published in the American Journal of Clinical Nutrition, aimed to fill in some of these gaps. We looked at small molecules in the body—called metabolites—including those that are produced when food is digested by both our bodies and the microbes in our gut.
We studied healthy adults without obesity and fed them two different diets:
• A high-fiber diet (called the Microbiome Enhancer Diet or MBD), which was low in processed foods.
• A Western-style diet (WD), which was low in fiber and high in processed foods.
Both diets had the same number of calories and macronutrient percentages, and participants were carefully monitored to make sure they ate exactly what was provided.
Our study goals were:
1. To find chemical “fingerprints” of each diet that could be validated in future research.
2. To understand how diet and gut microbes work together to affect how much energy the body absorbs.
What we found:
1. The high-fiber diet changed many of the body’s metabolites compared to the processed diet. These changes could help identify diets that modulate how much energy is absorbed from the diet, in part by altering the gut microbiome.
2. Some of the changes in metabolites excreted in the stool were linked to less energy being absorbed and more growth of gut microbes—suggesting potential mechanisms by which the microbes might be using some of the energy themselves and preventing energy from being absorbed by the host.
3. Surprisingly, the high-fiber diet increased levels of a ketone body called beta-hydroxybutyrate, which usually rises during fasting or low-carb diets. This happened even though both diets had the same number of calories which were calculated to maintain participants’ starting body weight, hinting that an MBD might mimic some effects of fasting.
Why this matters:
These findings help us understand how diet and gut microbes work together to influence energy use in the body. This could lead to new ways to prevent or treat obesity by targeting the gut microbiome.
To read the full published article please click below.
Recent News
Bringing Cancer Research Into the Home: Dr. Justin Brown's Approach to Trial Design
Justin Brown, PhD, Associate Investigator at AdventHealth, has dedicated his career to studying how exercise can improve outcomes for cancer patients after losing his father to colon cancer as a...
Exercise as “Powerful Medicine”: Spotlight on AdventHealth Research
Recently, Dr. Bret Goodpaster, scientific director of the AdventHealth Translational Research Institute (TRI), appeared on FOX 35 News to discuss groundbreaking research exploring how exercise impacts...
New Study Points to Promising Way to Protect Kidneys in Type 1 Diabetes
Richard E. Pratley, M.D., senior investigator and diabetes program lead at the AdventHealth Translational Research Institute (TRI), served as one of the lead researchers on the international FINE-ONE...
Understanding Hypoglycemia and the CLEAR Study
The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...
Recognizing the Unrecognized: Advancing Research in Childhood Sjögren’s Disease
Sjögren’s disease has been recognized in adults for almost a century, first described by Swedish ophthalmologist Henrik Sjögren in the early 20th century. One of the biggest challenges in recognizing...
Did you know? Women, Hormones, and Heart Risk
Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...
Weight-Loss Drugs, Hormones, and Midlife: What Women Need to Know
Understanding the connection between GLP-1 medications and hormone therapy
Women, Brain Health, and the Alzheimer’s Puzzle
Why scientists are taking a closer look at why women face higher Alzheimer’s risk
Clinical Trial Evidence on Diet and Type 1 Diabetes Outcomes
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes.
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.
AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial
On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.